Cymabay Therapeutics Inc Asset Turnover Ratio (CBAY), as of fourth quarter 2023, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Cymabay Therapeutics Inc   (NASDAQ: CBAY)
 

Cymabay Therapeutics Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Cymabay Therapeutics Inc 's asset turnover ratio, the ratio that measures the ability of Cymabay Therapeutics Inc 's assets to generate revenue, sequentially decreased to 0.09 in the fourth quarter (Dec 31 2023), but it does not raise any concerns as Cymabay Therapeutics Inc continue to execute well, and the asset turnover ratio remains above the average.

Within sector Cymabay Therapeutics Inc achieved the highest asset turnover ratio. While asset turnover ranking remained unchanged in the fourth quarter 2023 compared to previous quarter at no. .

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CBAY Asset Turnover Ratio (Dec 31 2023)
IV. Quarter		 (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter
Y / Y Asset Change 207.67 % 183.24 % 27.53 % 22.27 % -30.74 %
Y / Y Revenue Change - - - - -
Asset Turnover Ratio (TTM) 0.09 - 0.16 - -
CBAY's Total Ranking # # # # #
Seq. Asset Change -3.29 % 99.01 % -7.61 % 73.04 % -10.97 %
Seq. Revenue Change - - - - -



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall Market #

Asset Turnover Ratio Statistics
High Average Low
0 0 0
 




CBAY Company Profile • Back to CBAY Efficiency Comparisons • Compare CBAY Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Dec 31 2023, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Dec 31 2023 Assets at quarter ending Dec 31 2023
T2 Biosystems Inc   0.19 $ 7.193  Millions$ 36.985  Millions
Jaguar Health Inc   0.19 $ 9.761  Millions$ 51.311  Millions
Butterfly Network Inc   0.19 $ 65.856  Millions$ 346.191  Millions
Nektar Therapeutics  0.19 $ 90.122  Millions$ 474.075  Millions
Dariohealth Corp   0.19 $ 19.984  Millions$ 107.016  Millions
Macrogenics Inc   0.18 $ 58.749  Millions$ 321.885  Millions
Arcutis Biotherapeutics Inc   0.18 $ 59.606  Millions$ 333.618  Millions
Petros Pharmaceuticals inc   0.18 $ 5.822  Millions$ 33.002  Millions
Repare Therapeutics Inc   0.17 $ 51.133  Millions$ 294.551  Millions
Immunome Inc   0.17 $ 14.018  Millions$ 82.812  Millions
Enanta Pharmaceuticals Inc  0.17 $ 73.622  Millions$ 436.541  Millions
Xortx Therapeutics inc   0.17 $ 0.919  Millions$ 5.468  Millions
Ligand Pharmaceuticals Incorporated  0.17 $ 131.314  Millions$ 781.406  Millions
Biontech Se  0.17 $ 4,277.280  Millions$ 25,767.056  Millions
Durect Corp  0.17 $ 8.548  Millions$ 51.731  Millions
Arcellx Inc   0.16 $ 110.319  Millions$ 671.455  Millions
Whitehawk Therapeutics Inc   0.16 $ 24.354  Millions$ 148.491  Millions
Profound Medical Corp   0.16 $ 7.199  Millions$ 43.911  Millions
Innovative Eyewear Inc   0.16 $ 1.152  Millions$ 7.197  Millions
Tvardi Therapeutics Inc   0.16 $ 20.968  Millions$ 132.212  Millions
Adagene Inc   0.16 $ 18.111  Millions$ 115.729  Millions
Cyclo Therapeutics Inc   0.16 $ 1.076  Millions$ 6.896  Millions
Editas Medicine Inc   0.16 $ 78.123  Millions$ 502.465  Millions
Marinus Pharmaceuticals Inc   0.15 $ 30.989  Millions$ 199.933  Millions
Adc Therapeutics Sa  0.15 $ 69.558  Millions$ 449.164  Millions
Legend Biotech Corporation  0.15 $ 285.143  Millions$ 1,848.609  Millions
Maxcyte inc   0.15 $ 41.288  Millions$ 271.937  Millions
2seventy Bio Inc   0.15 $ 100.387  Millions$ 663.596  Millions
Bionano Genomics Inc   0.15 $ 36.116  Millions$ 239.960  Millions
Biocorrx Inc   0.15 $ 0.089  Millions$ 0.597  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.